Patents by Inventor Timothy Scott Johnson

Timothy Scott Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11980207
    Abstract: Provided are methods for producing food products comprising recombinant components, and compositions used in and food products produced by such methods.
    Type: Grant
    Filed: April 23, 2021
    Date of Patent: May 14, 2024
    Assignee: Perfect Day, Inc.
    Inventors: Timothy Geistlinger, Heather Jensen, Ravirajsinh Jhala, Hendrik Meerman, Balakrishnan Ramesh, Ty Wagoner, Timothy Scott Johnson, Vincent Wei-Xiang Wu, Francesca Manea
  • Patent number: 11975046
    Abstract: The present invention relates to methods for the treatment of fibrosis. The invention discloses new research which demonstrates that interferon-lambda has directly acting anti-fibrotic effects both in vitro and in vivo and may be used to provide effective new therapies for the treatment of multiple types of fibrosis.
    Type: Grant
    Filed: June 29, 2023
    Date of Patent: May 7, 2024
    Assignees: UCB BIOPHARMA SRL, FIVE PRIME THERAPEUTICS, INC.
    Inventors: Timothy Scott Johnson, Breda Twomey, Janine Powers, Danielle E. Kellar
  • Publication number: 20240034760
    Abstract: The present invention relates generally to a recombinant protein, compositions comprising such recombinant protein, and to methods for producing such recombinant protein and compositions.
    Type: Application
    Filed: August 5, 2021
    Publication date: February 1, 2024
    Applicant: Perfect Day, Inc.
    Inventors: Timothy Scott Johnson, Timothy Geistlinger, Ty B. Wagoner, Janine Tsan-Huei Lin
  • Publication number: 20240026279
    Abstract: The present disclosure relates to methods and compositions for producing a recombinant component for use in a food or other product. The present disclosure further relates to compositions comprising the recombinant component produced by such methods and compositions.
    Type: Application
    Filed: November 15, 2021
    Publication date: January 25, 2024
    Inventors: TIMOTHY GEISTLINGER, HEATHER JENSEN, RAVIRAJSINH JHALA, HENDRIK MEERMAN, BALAKRISHNAN RAMESH, TIMOTHY SCOTT JOHNSON, VINCENT WEI-XIANG WU, FRANCESCA MANEA, TY WAGONER
  • Publication number: 20240000893
    Abstract: The present invention relates to methods for the treatment of fibrosis. The invention discloses new research which demonstrates that interferon-lambda has directly acting anti-fibrotic effects both in vitro and in vivo and may be used to provide effective new therapies for the treatment of multiple types of fibrosis.
    Type: Application
    Filed: June 29, 2023
    Publication date: January 4, 2024
    Applicants: UCB BIOPHARMA SRL, FIVE PRIME THERAPEUTICS, INC.
    Inventors: Timothy Scott JOHNSON, Breda TWOMEY, Janine POWERS, Danielle E. KELLAR
  • Publication number: 20220033788
    Abstract: Provided are methods for producing food products comprising recombinant components, and compositions used in and food products produced by such methods.
    Type: Application
    Filed: October 17, 2019
    Publication date: February 3, 2022
    Inventors: Timothy Geistlinger, Heather Jensen, Ravirajsinh Jhala, Hendrik Meerman, Balakrishnan Ramesh, Ty Wagoner, Timothy Scott Johnson, Vincent Wei-Xiang Wu, Francesca Manea
  • Publication number: 20210329941
    Abstract: Provided are methods for producing food products comprising recombinant components, and compositions used in and food products produced by such methods.
    Type: Application
    Filed: April 23, 2021
    Publication date: October 28, 2021
    Inventors: Timothy Geistlinger, Heather Jensen, Ravirajsinh Jhala, Hendrik Meerman, Balakrishnan Ramesh, Ty Wagoner, Timothy Scott Johnson, Vincent Wei-Xiang Wu, Francesca Manea
  • Publication number: 20190374610
    Abstract: The present invention relates to methods for the treatment of fibrosis. The invention discloses new research which demonstrates that interferon-lambda has directly acting anti-fibrotic effects both in vitro and in vivo and may be used to provide effective new therapies for the treatment of multiple types of fibrosis.
    Type: Application
    Filed: December 20, 2017
    Publication date: December 12, 2019
    Inventors: Timothy Scott Johnson, Breda Twomey, Janine Powers